苏中地区344例原发性肝癌预后因素分析  

Analysis on prognosis factors and therapeutic efficacy of 344 patients with primary hepatic carcinoma in central district of Jiangsu province in China

作　　者：鲍丽静[1] 向晓星[1] 蒋玉兰[2] 朱海杭[1] 龙爱华[1] 

机构地区：[1]苏北人民医院消化病科,扬州225001 [2]苏北人民医院医学检验中心,扬州225001

出　　处：《江苏医药》2010年第6期654-655,共2页Jiangsu Medical Journal

摘　　要：目的探讨苏中地区原发性肝癌(肝癌)患者的预后因素。方法对苏中地区344例肝癌患者的临床资料以及与疾病预后可能相关的17项临床与生化指标进行统计分析。结果与几年前比较,苏中地区肝癌患者的发病年龄、甲胎蛋白阳性率、手术与局部治疗比例等指标均发生较大变化。肿瘤数目、有无癌栓、γ-GT三项指标与疾病预后密切相关。结论苏中地区肝癌患者的临床特点正在发生变化,肿瘤数目、有无癌栓、γ-GT可以评估疾病预后。肺癌的治疗方法仍较单一。Objective To explore the prognostic factors for patients with primary hepatic carcinoma（PHC） in central district of Jiangsu province,China.Methods Clinical data and 17 clinical and biochemical items which might be related to the prognosis of 344 patients with PHC were statistically analyzed.Results Compared with the data of several years ago,significant changes had been taken place in age,positive rate of serum alpha-fetoprotein and proportions of operation and local treatment in PHC patients.The tumor number,with or without embolism in the portal vein,and serum level of GGT were the factors closely correlated to the prognosis of PHC.Conclusion The clinical features of PHC in central district of Jiangsu province have been changing.Some clinical indicators might be used for predicting the prognosis of PHC.The treatment methods for PHC are relatively simplex.

关 键 词：原发性肝癌 预后 

分 类 号：R735[医药卫生—肿瘤]